Baloise Holding AG

LSE:0QQ3 Stock Report

Market Cap: CHF 7.6b

Baloise Holding Valuation

Is 0QQ3 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0QQ3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0QQ3 (CHF168.5) is trading below our estimate of fair value (CHF241.19)

Significantly Below Fair Value: 0QQ3 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0QQ3?

Key metric: As 0QQ3 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0QQ3. This is calculated by dividing 0QQ3's market cap by their current earnings.
What is 0QQ3's PE Ratio?
PE Ratio30.1x
EarningsCHF 253.70m
Market CapCHF 7.64b

Price to Earnings Ratio vs Peers

How does 0QQ3's PE Ratio compare to its peers?

The above table shows the PE ratio for 0QQ3 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average21.6x
AV. Aviva
10.1x4.2%UK£12.9b
LGEN Legal & General Group
46x28.0%UK£12.9b
PRU Prudential
24.1x28.4%UK£16.9b
HSX Hiscox
6.1x-2.4%UK£3.5b
0QQ3 Baloise Holding
30.1x15.6%CHF 7.6b

Price-To-Earnings vs Peers: 0QQ3 is expensive based on its Price-To-Earnings Ratio (30.1x) compared to the peer average (21.6x).

Price to Earnings Ratio vs Industry

How does 0QQ3's PE Ratio compare vs other companies in the European Insurance Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
0QQ3 30.1xIndustry Avg. 11.8xNo. of Companies13PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0QQ3 is expensive based on its Price-To-Earnings Ratio (30.1x) compared to the European Insurance industry average (11.9x).

Price to Earnings Ratio vs Fair Ratio

What is 0QQ3's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0QQ3 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio30.1x
Fair PE Ratio16.8x

Price-To-Earnings vs Fair Ratio: 0QQ3 is expensive based on its Price-To-Earnings Ratio (30.1x) compared to the estimated Fair Price-To-Earnings Ratio (16.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0QQ3 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 168.50
CHF 168.64
+0.08%
6.5%CHF 190.00CHF 155.00n/a7
Nov ’25CHF 167.60
CHF 166.07
-0.9%
7.8%CHF 190.00CHF 146.00n/a7
Oct ’25CHF 172.50
CHF 166.75
-3.3%
8.3%CHF 190.00CHF 146.00n/a6
Sep ’25CHF 162.74
CHF 152.00
-6.6%
2.3%CHF 155.00CHF 146.00n/a4
Aug ’25CHF 157.50
CHF 152.00
-3.5%
2.3%CHF 155.00CHF 146.00n/a4
Jul ’25CHF 158.20
CHF 151.25
-4.4%
2.2%CHF 155.00CHF 146.00n/a4
Jun ’25CHF 154.30
CHF 151.25
-2.0%
2.2%CHF 155.00CHF 146.00n/a4
May ’25CHF 138.80
CHF 151.25
+9.0%
2.2%CHF 155.00CHF 146.00n/a4
Apr ’25CHF 141.28
CHF 145.00
+2.6%
2.2%CHF 149.00CHF 140.00n/a4
Mar ’25CHF 142.87
CHF 147.75
+3.4%
1.6%CHF 151.00CHF 145.00n/a4
Feb ’25CHF 138.89
CHF 146.75
+5.7%
1.7%CHF 151.00CHF 145.00n/a4
Jan ’25CHF 131.80
CHF 145.50
+10.4%
2.7%CHF 151.00CHF 140.00n/a4
Dec ’24CHF 133.92
CHF 149.25
+11.4%
3.8%CHF 159.00CHF 145.00n/a4
Nov ’24CHF 130.50
CHF 153.50
+17.6%
4.3%CHF 161.00CHF 147.00CHF 167.604
Oct ’24CHF 133.61
CHF 156.75
+17.3%
3.6%CHF 161.00CHF 147.00CHF 172.504
Sep ’24CHF 138.81
CHF 156.75
+12.9%
3.6%CHF 161.00CHF 147.00CHF 162.744
Aug ’24CHF 135.57
CHF 156.40
+15.4%
3.3%CHF 161.00CHF 147.00CHF 157.505
Jul ’24CHF 131.40
CHF 156.40
+19.0%
3.3%CHF 161.00CHF 147.00CHF 158.205
Jun ’24CHF 140.00
CHF 156.40
+11.7%
3.3%CHF 161.00CHF 147.00CHF 154.305
May ’24CHF 148.91
CHF 156.40
+5.0%
3.3%CHF 161.00CHF 147.00CHF 138.805
Apr ’24CHF 142.40
CHF 156.40
+9.8%
3.3%CHF 161.00CHF 147.00CHF 141.285
Mar ’24CHF 156.20
CHF 157.60
+0.9%
6.0%CHF 174.00CHF 147.00CHF 142.875
Feb ’24CHF 150.26
CHF 157.60
+4.9%
6.0%CHF 174.00CHF 147.00CHF 138.895
Jan ’24CHF 142.70
CHF 155.20
+8.8%
8.2%CHF 174.00CHF 135.00CHF 131.805
Dec ’23CHF 143.51
CHF 155.20
+8.1%
8.2%CHF 174.00CHF 135.00CHF 133.925
Nov ’23CHF 136.81
CHF 156.64
+14.5%
8.0%CHF 174.00CHF 135.00CHF 130.505

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Beazley

UK£4.9b

Provides risk insurance and reinsurance solutions in the United States, the United Kingdom, rest of Europe, and internationally.

BEZL

UK£7.79

7D

6.0%

1Y

38.1%

Grupo Catalana Occidente

€4.3b

Provides insurance products and services worldwide.

0NRN

€36.25

7D

-2.9%

1Y

14.4%

Swiss Re

CHF 28.1b

Provides wholesale reinsurance, insurance, other insurance-based forms of risk transfer, and other insurance-related services worldwide.

SRENZ

CHF 96.62

7D

2.0%

1Y

4.1%